Meal Timing and Sleep for Metabolic Health in Healthy Subjects
(DT2 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how dinner timing might affect metabolism and sleep in healthy adults. Researchers will compare the effects of eating dinner early (Early Dinner) or late (Late Dinner) and examine how delaying sleep might further impact the body's ability to process nutrients and fats. Participants will be divided into groups to try different combinations of eating and sleeping times. The trial seeks healthy adults who usually go to bed before 1:00 A.M. and do not have any sleep disorders or metabolic diseases. As an unphased trial, it offers participants the opportunity to contribute to understanding how lifestyle changes can impact health.
Will I have to stop taking my current medications?
The trial requires that you do not use medications that can affect circadian rhythm, such as beta blockers and melatonin. If you are taking these, you would need to stop before participating.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that dinner timing can affect health, but changing meal times is generally safe. Studies have found that eating dinner earlier may improve energy processing, benefiting metabolism. Specifically, the body might manage sugars and fats more effectively with earlier meals.
Conversely, a late dinner might hinder fat burning, which could be less beneficial for metabolism. However, this doesn't imply it's unsafe; it just might not align with certain health goals.
Eating dinner and going to bed later can reduce nighttime fat burning, affecting energy use. While not necessarily harmful, it might not be ideal for boosting metabolism.
Overall, most people can adjust meal times without issues. Studies have not reported major safety concerns. Participants in similar studies adapted well, experiencing no serious side effects.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how the timing of meals and sleep can impact metabolic health, which is a fresh approach compared to traditional methods like diet adjustments or medication. Unlike standard practices that often focus on what you eat, this study looks at when you eat and sleep, offering a new angle on metabolic regulation. By using stable isotopes to measure fat oxidation, the trial can provide deeper insights into the body's metabolic processes, potentially leading to novel strategies for maintaining or improving metabolic health. This could pave the way for personalized lifestyle recommendations that are easy to implement and could complement or enhance existing health strategies.
What evidence suggests that this trial's treatments could be effective for metabolic health?
This trial will compare different meal timing and sleep patterns. Studies have shown that eating dinner late can disrupt how the body processes sugar and fat, potentially leading to weight gain and other health issues. Participants will experience various meal timings, including a late dinner, which might affect energy use during sleep. Research suggests that eating dinner earlier can aid in weight loss and help avoid these issues. Another part of the trial will examine the effects of eating late and going to bed even later, which can disrupt the body's internal clock and possibly lead to obesity. Eating dinner earlier may help maintain the body's natural rhythms, improving overall health.12367
Who Is on the Research Team?
Jonathan Jun, MD
Principal Investigator
Johns Hopkins University
Are You a Good Fit for This Trial?
This trial is for healthy adults aged 18-30, with a BMI of 18-30 kg/m2 and normal sleep patterns (bedtime before 1:00 A.M. and mid-sleep before 5 A.M.). Participants should not be smokers or have conditions like diabetes, sleep disorders, GERD that affects eating near bedtime, or use medications affecting circadian rhythms.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a 3-arm randomized crossover study to assess the metabolic impact of early and late dinner times relative to DLMO, with serial blood sampling and sleep studies
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Early dinner
- Late Dinner
- Late Dinner + Late Sleep
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
National Cancer Institute (NCI)
Collaborator
National Marrow Donor Program
Collaborator
University of Arkansas
Collaborator